In 2023, China Medical System Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, China Medical System Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020-2019 |
|---|---|---|---|---|
Total Scope 1 | 1,628.4a | 5,391.4b | 5,540.3b | |
Total Scope 2 | ||||
Unspecified Calculation Method | 4,131a | 4,470.2b | 4,866.8b | |
Total Scope 3 | N/A | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 1.4442a | 4.1027b | 4.2344b |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2023, the total operational greenhouse gas (GHG) emissions of China Medical System Holdings amounted to 5,759.4 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of China Medical System Holdings decreased by 41.6%, showing that the company has made progress in taking action to reduce the climate impact of its operations.ab
In 2023, the total Scope 1 emissions of China Medical System Holdings were 1,628.4 metric tons of CO₂ equivalent (tCO₂e).a
Since 2020, China Medical System Holdings's Scope 1 emissions have decreased by 72.38%, reflecting a declining long-term trend in Scope 1 emissions over time.a
Compared to the previous year (2022), China Medical System Holdings's Scope 1 emissions decreased by 69.8%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.ab
In 2023, China Medical System Holdings reported Scope 2 greenhouse gas (GHG) emissions of 4,131 tCO₂e without specifying the calculation method.a
Since 2020, China Medical System Holdings's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 38.22%, reflecting a declining long-term trend in Scope 2 emissions over time.a
Compared to the previous year (2022), China Medical System Holdings's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that China Medical System Holdings's emissions have plateaued with no significant change in its energy consumption footprint.ab
In 2023, China Medical System Holdings reported its Scope 2 emissions using an unspecified methodology.a
In 2023, China Medical System Holdings reported Scope 1 greenhouse gas (GHG) emissions of 1,628.4 tCO₂e and total revenues of USD 1,128 millions. This translates into an emissions intensity of 1.44 tCO₂e per millions USD.a
In 2023, China Medical System Holdings reported a Scope 1 emissions intensity of 1.44 tCO₂e per millions USD. Compared to the peer group median of 17.4, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2023, China Medical System Holdings ranked 4 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places China Medical System Holdings among the top performers, with one of the lowest emissions intensities relative to peers.a